Athanor Capital, LP - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 118 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.52 and the average weighting 0.1%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$524,000
+94.8%
17,631
+42.0%
0.01%
+20.0%
Q3 2020$269,000
-54.3%
12,420
-52.9%
0.01%
-66.7%
Q2 2020$588,000
+3.0%
26,349
+5.9%
0.03%
+15.4%
Q4 2019$571,00024,8710.03%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$10,475,0003.58%
NEA Management Company, LLC 4,912,306$56,590,0001.64%
RA Capital Management 4,871,067$56,115,0001.22%
Pinz Capital Management, LP 148,475$1,710,0001.07%
Samsara BioCapital, LLC 345,293$3,978,0001.00%
Bell & Brown Wealth Advisors, LLC 117,400$1,352,0000.61%
Rock Springs Capital Management LP 1,237,026$14,251,0000.36%
ACT CAPITAL MANAGEMENT, LLC 27,500$317,0000.34%
Endurant Capital Management LP 105,792$1,219,0000.32%
Baker Brothers Advisors 4,125,062$47,521,0000.27%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders